Literature DB >> 32045710

Socioeconomic and demographic disparities of moyamoya disease in the United States.

Arash Ghaffari-Rafi1, Shadeh Ghaffari-Rafi2, Jose Leon-Rojas3.   

Abstract

OBJECTIVES: Although stroke incidence is inversely associated with socioeconomic status, whether similar disparities exist with moyamoya disease (MMD) is unknown. Determining the socioeconomic and demographic factors involved in MMD will provide better direction in elucidating the etiology or addressing healthcare inequalities. PATIENTS AND METHODS: To investigate MMD incidence with respect to sex, age, income, residence, and race/ethnicity, we examined the largest American administrative dataset, the National (Nationwide) Inpatient Sample (NIS), which surveys 20 % of United States discharges irrespective of payor. We then determined median annual incidence per 100,000 people and trends between 2008-2015.
RESULTS: Overall MMD incidence (with 25th and 75th quartiles) was 0.293 (0.283, 0.324) and annually increasing (τ = 0.857, p = 0.004). Females had an incidence of 0.398 (0.371, 0.464), larger (p = 0.008) than the male incidence of 0.185 (0.165, 0.195). Amongst age groups incidence varied (χ2 = 8.857, p = 0.012) as follows: 1-17 years old group, 0.298 (0.259, 0.346); 18-44 group, 0.380 (0.346, 0.412); 45-64 group, 0.308 (0.280, 0.328). Those 18-44 ha d a significantly larger incidence relative to the 1-17 (p = 0.039) and 45-64 (p = 0.008) groups. Individuals with low income had an incidence of 0.514, larger (p = 0.008) than the 0.239 of middle/high income patients. Depending on whether the patients lived in an urban, suburban, or rural community, incidence differed (χ2 = 7.6, p = 0.022) as follows, respectively: 0.344 (0.293, 0.371); 0.269 (0.258, 0.294); 0.283 (0.273, 0.293). Living in an urban community resulted in a significantly greater incidence, relative to suburban (p = 0.016) or rural (p = 0.032). Amongst race/ethnicity (χ2 = 7.6, p = 0.022), incidence for Asian/Pacific Islanders, Blacks, Whites, and Hispanics between 2008-2013 was as follows, respectively: 0.509 (0.429, 0.595); 0.292 (0.219, 0.356); 0.148 (0.137, 0.157); 0.121 (0.075, 0.153). Other than comparisons between Whites and Blacks/Hispanics, incidence significantly varied between all groups. Annually incidence was significantly increasing for females (τ = 0.929, p = 0.002), ages 18-44 (τ = 0.786, p = 0.009), ages 45-64 (τ = 0.714, p = 0.019), middle/high income (τ = 0.786, p = 0.009), and urban (τ = 0.714, p = 0.019) or suburban (τ = 0.714, p = 0.035) dwelling patients.
CONCLUSION: MMD diagnoses between 2008-2015 have been significantly increasing in the United States, with disparities growing between socioeconomic and demographic strata. Disproportionately, incidence was greatest for patients who were low income, urban living, female, aged 18-44, and Asian/Pacific Islanders. This data highlights a growing healthcare inequality amongst MMD and provides direction in etiology elucidation.
Copyright © 2020 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Demographics; Disparities; Incidence; Moyamoya disease; Socioeconomic

Mesh:

Year:  2020        PMID: 32045710     DOI: 10.1016/j.clineuro.2020.105719

Source DB:  PubMed          Journal:  Clin Neurol Neurosurg        ISSN: 0303-8467            Impact factor:   1.876


  5 in total

1.  Morning glory disc anomaly associated with moyamoya disease and pituitary stalk duplication.

Authors:  Mohamed M Khodeiry; Viet Q Chau; Anas Yasin; Robert M Starke; Shahnaz Miri; Joshua Pasol
Journal:  Am J Ophthalmol Case Rep       Date:  2022-06-24

2.  Editorial for "Pre-Surgical Magnetic Resonance Imaging Indicators of Revascularization Response in Adults With Moyamoya Vasculopathy".

Authors:  Yibin Xie
Journal:  J Magn Reson Imaging       Date:  2022-03-17       Impact factor: 5.119

3.  Identification of associations and distinguishing moyamoya disease from ischemic strokes of other etiologies: A retrospective case-control study.

Authors:  Cori Xiu Yue Sutton; Enrique Carrazana; Catherine Mitchell; Jason Viereck; Kore Kai Liow; Arash Ghaffari-Rafi
Journal:  Ann Med Surg (Lond)       Date:  2022-05-11

4.  Incidence and prevalence of moyamoya disease in urban China: a nationwide retrospective cohort study.

Authors:  Yixin Sun; Guoyu Zhou; Jingnan Feng; Lu Chen; Guozhen Liu; Jinxi Wang; Qingliang Wang; Junyou Yu; Xiwang Yang; Zheng Yang; Pei Gao; Shengfeng Wang; Siyan Zhan
Journal:  Stroke Vasc Neurol       Date:  2021-05-03

Review 5.  Western Moyamoya Phenotype: A Scoping Review.

Authors:  Raphael Miller; Santiago R Unda; Ryan Holland; David J Altschul
Journal:  Cureus       Date:  2021-11-22
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.